Hungary, Estonia and Iceland have been the first to join the VaccineGuard test developed by Guardtime, whose new platform aims to coordinate global vaccination programs with reliable vaccine certifications.
VaccineGuard will be able to display critical data, provide information on the distribution and administration of vaccines, monitor compliance with national and local regulations, and thus determine the eligibility of individual citizens for the vaccine, as well as when they can be included in the vaccination program. It also provides real-time data to the health authorities about the vaccination program and its results 24 hours a day.
The platform sends automated reports on vaccination sites, monitors vaccination stocks, and allows you to report potential side effects so they can be investigated faster and more efficiently than ever before.
As the Hungarian news portal 24.hu reports, the Estonian subsidiary of AstraZeneca participates in the experiment, which can provide reliable feedback on vaccination between manufacturers, healthcare providers, authorities and citizens.
As the chief physician of Guardtime said: “We are proud that Iceland, Estonia and Hungary have joined us to test our new development. These countries are among the most active and successful developing states in defence against coronavirus. We look forward to working with them on this project and sharing our results with other countries so that we can return to our normal lives as soon as possible.”
According to the website of Guardtime, VaccineGuard can also be particularly useful for governments because they do not store personal data, and do not have to build new infrastructure as it operates digitally and on paper as well, and are easy to integrate into existing IT systems; furthermore, they are a huge step forward in monitoring vaccination.
VaccineGuard records whether citizens have already vaccinated themselves, but test results can also be applied to the surface.
Last October, the Estonian government and the World Health Organization (WHO) agreed on the development of a digital vaccine certificate in order to speed up the COVAX process. As part of this, the development of Guardtime has been realized.
Source: 24.hu; guardtime.com